Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Tax Provisions (2019 - 2025)

Xtant Medical Holdings has reported Tax Provisions over the past 7 years, most recently at $1.5 million for Q4 2025.

  • Quarterly Tax Provisions rose 7238.1% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, up 984.49% year-over-year, with the annual reading at $2.0 million for FY2025, 984.49% up from the prior year.
  • Tax Provisions was $1.5 million for Q4 2025 at Xtant Medical Holdings, up from $257000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $2.5 million in Q4 2023 and troughed at -$2.3 million in Q3 2023.
  • The 5-year median for Tax Provisions is $23000.0 (2021), against an average of $136052.6.
  • The largest YoY upside for Tax Provisions was 11700.0% in 2023 against a maximum downside of 17792.31% in 2023.
  • A 5-year view of Tax Provisions shows it stood at $30000.0 in 2021, then decreased by 30.0% to $21000.0 in 2022, then surged by 11700.0% to $2.5 million in 2023, then tumbled by 99.15% to $21000.0 in 2024, then soared by 7238.1% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Tax Provisions are $1.5 million (Q4 2025), $257000.0 (Q3 2025), and $255000.0 (Q2 2025).